Breaking News Instant updates and real-time market news.

JAZZ

Jazz Pharmaceuticals

$140.98 /

-0.98 (-0.69%)

13:08
02/17/20
02/17
13:08
02/17/20
13:08

Jazz, PharmaMar announce FDA acceptance, priority review NDA for lurbinectedin

PharmaMar and Jazz Pharmaceuticals announce that the U.S. Food and Drug Administration accepted for filing with Priority Review the New Drug Application seeking accelerated approval for lurbinectedin for the treatment of patients with Small Cell Lung Cancer who have progressed after prior platinum-containing therapy. The FDA has set a PDUFA target action date of August 16, 2020. PharmaMar submitted the NDA to FDA in December 2019 based on data from the Phase II monotherapy basket trial, which included evaluation of lurbinectedin for the treatment of relapsed SCLC. A total of 105 patients from 39 centers were recruited in Europe and the United States. The trial met its primary endpoint of the Objective Response Rate and the results were presented at the 55th Annual Meeting of the American Society of Clinical Oncology in June 2019. The FDA's accelerated approval pathway allowed for the submission of an NDA based on the results of Phase II drug investigations for the treatment of serious diseases that address an unmet medical need. There remains a critical unmet need for patients with relapsed SCLC, as the treatment landscape has not changed substantially in more than two decades since the last new chemical entity, topotecan, was approved. As previously announced in December 2019, PharmaMar and Jazz Pharmaceuticals have entered into an exclusive license agreement, which became effective in January 2020, granting Jazz U.S. commercialization rights to lurbinectedin.

  • 19

    Feb

  • 25

    Feb

JAZZ Jazz Pharmaceuticals
$140.98 /

-0.98 (-0.69%)

02/14/20 SunTrust
Pfenex initiated with a Buy at SunTrust
01/30/20 Craig-Hallum
Avadel Pharmaceuticals initiated with a Buy at Craig-Hallum
01/22/20 Wells Fargo
Revance, Amphastar named top 2020 Specialty Pharmaceuticals ideas at Wells Fargo
01/08/20 Goldman Sachs
Jazz Pharmaceuticals initiated with a Neutral at Goldman Sachs

TODAY'S FREE FLY STORIES

Recommendations
DSM price target lowered to EUR 95 from EUR 104 at Morgan Stanley » 13:21
03/30/20
03/30
13:21
03/30/20
13:21
RDSMY

DSM

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Croda price target lowered to 5,000 GBp from 5,200 GBp at Morgan Stanley » 13:20
03/30/20
03/30
13:20
03/30/20
13:20
COIHY

Croda International

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Covestro price target lowered to EUR 40 from EUR 50 at Morgan Stanley » 13:19
03/30/20
03/30
13:19
03/30/20
13:19
COVTY

Covestro

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
BASF price target lowered to EUR 53 from EUR 63 at Morgan Stanley » 13:18
03/30/20
03/30
13:18
03/30/20
13:18
BASFY

BASF

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Arkema price target lowered to EUR 89 from EUR 107 at Morgan Stanley » 13:17
03/30/20
03/30
13:17
03/30/20
13:17
ARKAY

Arkema

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Second Sight appoints Matthew Pfeffer as acting CEO » 13:17
03/30/20
03/30
13:17
03/30/20
13:17
EYES

Second Sight

$2.32 /

+0.015 (+0.65%)

The Company announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
NASDAQ market internals summary » 13:17
03/30/20
03/30
13:17
03/30/20
13:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Second Sight to wind down operations » 13:16
03/30/20
03/30
13:16
03/30/20
13:16
EYES

Second Sight

$2.32 /

+0.015 (+0.65%)

Against a background of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
AkzoNobel price target lowered to EUR 95 from EUR 100 at Morgan Stanley » 13:16
03/30/20
03/30
13:16
03/30/20
13:16
AKZOY

AkzoNobel

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
NYSE market internals summary » 13:16
03/30/20
03/30
13:16
03/30/20
13:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Air Liquide price target lowered to EUR 115 from EUR 121 at Morgan Stanley » 13:16
03/30/20
03/30
13:16
03/30/20
13:16
AIQUY

Air Liquide

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Second Sight to lay off approximately 84 of 108 employees » 13:16
03/30/20
03/30
13:16
03/30/20
13:16
EYES

Second Sight

$2.32 /

+0.015 (+0.65%)

Second Sight Medical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
CarMax Q4 will beat, but sales slowed in March, says William Blair » 13:11
03/30/20
03/30
13:11
03/30/20
13:11
KMX

CarMax

$56.57 /

-2.28 (-3.87%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Oshkosh announces award of $346.4M in orders from Army » 13:09
03/30/20
03/30
13:09
03/30/20
13:09
OSK

Oshkosh

$60.66 /

+2.69 (+4.64%)

Oshkosh Defense, an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
St. James's Place downgraded to Equal Weight from Overweight at Morgan Stanley » 13:08
03/30/20
03/30
13:08
03/30/20
13:08
STJPF

St. James's Place

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Scor downgraded to Underweight from Equal Weight at Morgan Stanley » 13:07
03/30/20
03/30
13:07
03/30/20
13:07
SCRYY

Scor

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Sampo Oyj downgraded to Equal Weight from Overweight at Morgan Stanley » 13:05
03/30/20
03/30
13:05
03/30/20
13:05
SAXPY

Sampo Oyj

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Cloudflare call volume above normal and directionally bullish » 13:05
03/30/20
03/30
13:05
03/30/20
13:05
NET

Cloudflare

$22.62 /

+0.72 (+3.29%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Biohaven investors overly focused on placebo-adjusted data, says Mizuho » 13:04
03/30/20
03/30
13:04
03/30/20
13:04
BHVN

Biohaven Pharmaceutical

$32.43 /

-2.85 (-8.08%)

Despite the positive…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
ECMOHO, China Resources Ng Fung enter into strategic partnership » 13:01
03/30/20
03/30
13:01
03/30/20
13:01
MOHO

ECMOHO

$10.47 /

-0.03 (-0.29%)

ECMOHO and China…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Agilent says annual meeting to be held in virtual format only » 13:01
03/30/20
03/30
13:01
03/30/20
13:01
A

Agilent

$71.61 /

+1.07 (+1.52%)

Agilent Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Legal & General downgraded to Underweight from Equal Weight at Morgan Stanley » 13:00
03/30/20
03/30
13:00
03/30/20
13:00
LGGNY

Legal & General

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Zurich Insurance upgraded to Overweight from Equal Weight at Morgan Stanley » 12:57
03/30/20
03/30
12:57
03/30/20
12:57
ZURVY

Zurich Insurance

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Second Sight trading halted, news pending  12:56
03/30/20
03/30
12:56
03/30/20
12:56
EYES

Second Sight

$2.14 /

-0.16 (-6.96%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Residential power usage to rise despite overall U.S. drop, says Raymond James » 12:56
03/30/20
03/30
12:56
03/30/20
12:56
NEP

NextEra Energy Partners

$42.25 /

+2.04 (+5.07%)

, AMRC

Ameresco

$15.42 /

+0.47 (+3.14%)

, AQN

Algonquin Power

$12.23 /

-0.018 (-0.15%)

, AY

Atlantica Yield

$21.76 /

-0.24 (-1.09%)

, FSLR

First Solar

$35.62 /

+ (+0.00%)

, TPIC

TPI Composites

$13.94 /

-0.15 (-1.06%)

U.S. power usage is set…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.